Skip to content

Clinical trials

Terminated Phase 2/3 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Japan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20091
20101
20112
20121
20131
20141
20152
20171
20182
20193
20205
20213
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Pfizer3
Alexion Pharmaceuticals, Inc.2
Theravance Biopharma2
AN2 Therapeutics, Inc1
AstraZeneca1
CSL Behring1
Denovo Biopharma LLC1
EMD Serono Research & Development Institute, Inc.1
Eastern Network of Cancer Immunological Therapy, Japan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease3
Inflammatory Bowel Diseases3
Colitis, Ulcerative2
Dementia2
Recurrence2
Schizophrenia2
Stomach Neoplasms2
Biliary Tract Neoplasms1
Brain Diseases1
COVID-191

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.